RedHill Biopharma Ltd. (RDHL) Form 6-K — Jun 22, 2026
RedHill Biopharma closed a private placement issuing 8,571,429 American Depositary Shares and accompanying warrants at a purchase price of $0.70 per ADS, generating approximately $6 million in upfront gross proceeds. The financing included Series A-1 and A-2 warrants exercisable immediately at $0.86 and $0.70 per ADS, respectively, which could yield an additional $13.4 million in gross proceeds if fully exercised to support near-term liquidity. H.C. Wainwright & Co.
Key figures
- Gross Proceeds
- 6000000
- Offering Price
- 0.7
- Shares Offered
- 8571429
- Total potential proceeds usd
- 19400000
- Potential warrant proceeds usd
- 13400000
- Series a1 warrant exercise price
- 0.86
- Series a2 warrant exercise price
- 0.7
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.